A Study to Evaluate the Perioperative Use of Dexmedetomidine in Pediatric Patients With Congenital Heart Disease

Trial Profile

A Study to Evaluate the Perioperative Use of Dexmedetomidine in Pediatric Patients With Congenital Heart Disease

Completed
Phase of Trial: Phase IV

Latest Information Update: 20 May 2016

At a glance

  • Drugs Dexmedetomidine (Primary)
  • Indications Sedation
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 20 May 2016 New trial record
    • 10 May 2016 Primary endpoint has been met. (In-hospital mortality), as per results published in the Anesthesia and Analgesia.
    • 10 May 2016 Results published in the Anesthesia and Analgesia
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top